PMC:7115396 / 4431-4575 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":122,"end":138},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"}],"text":"Using a live attenuated or inactivated vaccine is typically considered to be the most cost-effective means of controlling viral infections [14]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T64","span":{"begin":6,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Using a live attenuated or inactivated vaccine is typically considered to be the most cost-effective means of controlling viral infections [14]."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T4","span":{"begin":122,"end":138},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"Using a live attenuated or inactivated vaccine is typically considered to be the most cost-effective means of controlling viral infections [14]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T29","span":{"begin":0,"end":144},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Using a live attenuated or inactivated vaccine is typically considered to be the most cost-effective means of controlling viral infections [14]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"89","span":{"begin":122,"end":138},"obj":"Disease"}],"attributes":[{"id":"A89","pred":"tao:has_database_id","subj":"89","obj":"MESH:D001102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Using a live attenuated or inactivated vaccine is typically considered to be the most cost-effective means of controlling viral infections [14]."}